Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognosis

  • Open Access
    Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
    PETR KARASEK, NATALIA GABLO, JAN HLAVSA, IGOR KISS, PETRA VYCHYTILOVA-FALTEJSKOVA, MARKETA HERMANOVA, ZDENEK KALA, ONDREJ SLABY and VLADIMIR PROCHAZKA
    Cancer Genomics & Proteomics July 2018, 15 (4) 321-327; DOI: https://doi.org/10.21873/cgp.20090
  • Open Access
    Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors
    DIMITRIOS MORIS, IOANNIS NTANASIS-STATHOPOULOS, DIAMANTIS I. TSILIMIGRAS, MOHAMAD A. ADAM, CHIFU JEFFREY YANG, DAVID HARPOLE and STAMATIOS THEOCHARIS
    Cancer Genomics & Proteomics March 2018, 15 (2) 153-163;
  • Open Access
    WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    TETYANA DENYSENKO, LAURA ANNOVAZZI, PAOLA CASSONI, ANTONIO MELCARNE, MARTA MELLAI and DAVIDE SCHIFFER
    Cancer Genomics & Proteomics January 2016, 13 (1) 31-45;
  • Open Access
    Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas
    ANCA MARIA CIMPEAN, RALUCA AMALIA BALICA, IOAN CAIUS DOROS, NICOLAE CONSTANTIN BALICA, PUSA NELA GAJE, RAMONA AMINA POPOVICI and MARIUS RAICA
    Cancer Genomics & Proteomics January 2016, 13 (1) 75-81;
  • You have access
    Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
    INGIRIDUR SKIRNISDOTTIR and TOMAS SEIDAL
    Cancer Genomics & Proteomics January 2013, 10 (1) 27-34;
  • You have access
    Metastatic Biomarker Discovery Through Proteomics
    Lindsey T. Brinton, Teresa A. Brentnall, Jeffrey A. Smith and Kimberly A. Kelly
    Cancer Genomics & Proteomics November 2012, 9 (6) 345-355;
  • You have access
    Reduced Expression of BMPR-IB Correlates with Poor Prognosis and Increased Proliferation of Breast Cancer Cells
    SIVAN M. BOKOBZA, LIN YE, HOWARD E. KYNASTON, ROBERT E. MANSEL and WEN G. JIANG
    Cancer Genomics & Proteomics March 2009, 6 (2) 101-108;

Pages

  • Previous
  • 1
  • …
  • 482
  • 483
  • 484
  • 485
  • 486
  • 487
  • 488
  • 489
  • 490
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire